Daisuke Kotani, GI Medical Oncologist, Chief Physician at the Department of Gastrointestinal Oncology at the National Cancer Center Hospital East, Japan, shared a post on X about a paper by Eric Haines et al. published in Nature Cancer:
“The MEK-RAF molecular glue IK-595 Nature Cancer.
- Traps MEK-RAF complexes to prevent CRAF-mediated reactivation
- Wider therapeutic window: efficacy with transient exposure and lower toxicities.
- Potent in KRAS/BRAF-mutant CRC.”
Title: The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
Authors: Eric Haines, Michael Burke, Rachel Catterall, Victor De Jesus, Daniel Hidalgo, Bin Li, Joseph D. Manna, Ao Yang, Jill Cavanaugh, Sarah R. Wessell, Marta Sanchez-Martin, Alexander Ivliev, Wilmin Bartolini, Sergio Santillana, Jeffrey Ecsedy, Michelle X. Zhang, Sabine K. Ruppel
You can read the Full Article in Nature Cancer.

More posts featuring Daisuke Kotani.